Schwerin Boyle Capital Management’s Pfizer PFE Stock Holding History

Schwerin Boyle Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.3M	Sell	543,843 -40,925	-7%	-$1.09M	1.94%	20
2025 Q4	$14.6M	Sell	584,768 -6,592	-1%	-$166K	1.6%	22
2025 Q3	$15.1M	Sell	591,360 -10,225	-2%	-$252K	1.65%	23
2025 Q2	$14.6M	Sell	601,585 -88,900	-13%	-$2.07M	1.63%	23
2025 Q1	$17.5M	Sell	690,485 -28,940	-4%	-$757K	1.8%	19
2024 Q4	$19.1M	Buy	719,425 +3,700	+0.5%	+$100K	1.96%	17
2024 Q3	$20.7M	Sell	715,725 -59,400	-8%	-$1.73M	2.17%	15
2024 Q2	$21.7M	Buy	775,125 +58,850	+8%	+$1.62M	2.27%	15
2024 Q1	$19.9M	Buy	716,275 +132,050	+23%	+$3.66M	1.98%	17
2023 Q4	$16.8M	Buy	584,225 +12,000	+2%	+$363K	1.88%	19
2023 Q3	$19M	Sell	572,225 -187,750	-25%	-$6.64M	2.23%	16
2023 Q2	$27.9M	Buy	+759,975	New	+$29.6M	2.63%	15

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Schwerin Boyle Capital Management's PFE Position: Q1 2026 in Review

Schwerin Boyle Capital Management reduced its Pfizer (PFE) stake by 7% in Q1 2026, selling an estimated $1.09M and leaving 543,843 shares worth $15.3M. The position accounts for 1.94% of the portfolio, ranked #20.

Schwerin Boyle Capital Management first reported a position in PFE in Q2 2023 and has held it in 12 quarters since. The position peaked at $27.9M in Q2 2023. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Schwerin Boyle Capital Management held 543,843 shares of Pfizer worth $15.3M as of Q1 2026.
Schwerin Boyle Capital Management sold 40,925 Pfizer shares in Q1 2026, an estimated $1.09M.
Pfizer made up 1.94% of Schwerin Boyle Capital Management's portfolio in Q1 2026, its #20 holding.
Schwerin Boyle Capital Management first reported a position in Pfizer in Q2 2023 and has held it in 12 quarters since.
Schwerin Boyle Capital Management's Pfizer position peaked at $27.9M in Q2 2023.
2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Schwerin Boyle Capital Management's 13F filing for Q1 2026, filed 14 May 2026.